Key result
Novel radioreceptor assay for active ANF correlates strongly with standard RIA at r=~0.93.
Why the study?
A highly sensitive and specific assay for the active circulating form of atrial natriuretic factor in human plasma was needed to improve measurement accuracy.
A highly sensitive and specific radioreceptor assay was developed for measuring active circulating atrial natriuretic factor in human plasma.
Answers are grounded in this paper and cite their sources.
May support specific ANF research assays; leaves open clinical adoption without outcome data.
This highly sensitive radioreceptor assay (RRA) for the active circulating form of atrial natriuretic factor (ANF), fragment 99-126, in human plasma requires 125I-labeled ANF, bovine zona-glomerulosa membrane receptors, and amiloride HCl. The amiloride elicits an increase in the binding affinity of ANF to its receptors. ANF is extracted from human plasma with "Sep-Pak" cyano cartridges. After a 90-min incubation at 25 degrees C, bound and free fractions are separated by filtration. The ANF concentration that inhibits receptor binding of the radioligand by 50% is 12.4 fmol of unlabeled ANF per tube. The minimum detectable concentration is 0.2 fmol per tube. Using ANF-supplemented plasma samples, there was a good correlation (r = 0.99) between ANF concentrations found and those expected. Only the active circulating form of ANF fully cross-reacts in this assay, which confirms its high selectivity. Results correlated strongly (r = 0.93) for clinical samples tested by RRA and RIA.
No takes yet. Share an insight, caveat, or question.
Ong et al. (1988) studied this question. Radioreceptor assay (RRA) for ANF vs. Radioimmunoassay (RIA) was evaluated on Correlation between RRA and RIA for clinical samples (r = 0.93). A highly sensitive radioreceptor assay for the active circulating form of atrial natriuretic factor showed strong correlation with radioimmunoassay in clinical samples.
Synapse has enriched 10 related papers. Consider them for comparative context: